Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggrastat in Ambulance for Acute MI
NCT00300833Phase 4Unknown
- Sponsor
- Tzafon Medical Center
- Start
- Jan 2006
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tirofiban in myocardial infarction (MI), sponsored by Tzafon Medical Center. Primary endpoint: Mortality. Status: unknown.
02
Drugs
tirofiban
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00300833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300833.